• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 NSAID 的用于生物医学应用的配位化合物:最新进展和发展。

NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.

机构信息

Department of Chemistry & CICECO, Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.

Instituto de Investigação e Inovação em Saúde (i3S), R. Alfredo Allen 208, 4200-135 Porto, Portugal.

出版信息

Int J Mol Sci. 2022 Mar 5;23(5):2855. doi: 10.3390/ijms23052855.

DOI:10.3390/ijms23052855
PMID:35269997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8911414/
Abstract

After the serendipitous discovery of cisplatin, a platinum-based drug with chemotherapeutic effects, an incredible amount of research in the area of coordination chemistry has been produced. Other transition metal compounds were studied, and several new relevant metallodrugs have been synthetized in the past few years. This review is focused on coordination compounds with first-row transition metals, namely, copper, cobalt, nickel or manganese, or with zinc, which have potential or effective pharmacological properties. It is known that metal complexes, once bound to organic drugs, can enhance the drugs' biological activities, such as anticancer, antimicrobial or anti-inflammatory ones. NSAIDs are a class of compounds with anti-inflammatory properties used to treat pain or fever. NSAIDs' properties can be strongly improved when included in complexes using their compositional N and O donor atoms, which facilitate their coordination to metal ions. This review focuses on the research on this topic and on the promising or effective results that complexes of first-row transition metals and NSAIDs can exhibit.

摘要

顺铂作为一种具有化疗效果的铂类药物被偶然发现后,在配位化学领域产生了大量的研究。其他过渡金属化合物也得到了研究,并且在过去的几年中已经合成了几种新的相关金属药物。本篇综述主要关注具有第一过渡金属(如铜、钴、镍或锰)或锌的配位化合物,这些化合物具有潜在或有效的药理学性质。已知金属配合物与有机药物结合后可以增强药物的生物活性,如抗癌、抗菌或抗炎活性。非甾体抗炎药(NSAIDs)是一类具有抗炎特性的化合物,用于治疗疼痛或发热。当 NSAIDs 的组成 N 和 O 供体原子被包含在复合物中时,它们的性质可以得到极大的改善,这使得它们能够与金属离子配位。本篇综述主要关注这一课题的研究以及第一过渡金属和 NSAIDs 的配合物所表现出的有希望或有效的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e232/8911414/22501664bc2a/ijms-23-02855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e232/8911414/22501664bc2a/ijms-23-02855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e232/8911414/22501664bc2a/ijms-23-02855-g001.jpg

相似文献

1
NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments.基于 NSAID 的用于生物医学应用的配位化合物:最新进展和发展。
Int J Mol Sci. 2022 Mar 5;23(5):2855. doi: 10.3390/ijms23052855.
2
N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.作为生物有机金属抗菌和抗癌药物的氮杂环卡宾金属配合物
Future Med Chem. 2015;7(10):1305-33. doi: 10.4155/fmc.15.61.
3
Novel metals and metal complexes as platforms for cancer therapy.新型金属和金属配合物作为癌症治疗的平台。
Curr Pharm Des. 2010 Jun;16(16):1813-25. doi: 10.2174/138161210791209009.
4
Copper, gold and silver compounds as potential new anti-tumor metallodrugs.铜、金和银的化合物作为有潜力的新型抗肿瘤金属药物。
Future Med Chem. 2010 Oct;2(10):1591-608. doi: 10.4155/fmc.10.234.
5
Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.新型非甾体类抗炎药托芬那酸、甲芬那酸和氟芬那酸与菲咯啉功能混合铜(II)配合物的氧化还原循环和插入特性:结构、SOD 模拟活性、与白蛋白的相互作用、DNA 损伤研究和抗癌活性。
J Inorg Biochem. 2019 May;194:97-113. doi: 10.1016/j.jinorgbio.2019.02.010. Epub 2019 Feb 23.
6
Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.钒、钌和铜化合物:一类具有抗癌活性的新型非铂金属药物。
Curr Med Chem. 2017;24(2):112-148. doi: 10.2174/0929867323666160824162546.
7
Bioactive luminescent transition-metal complexes for biomedical applications.用于生物医学应用的生物活性发光过渡金属配合物。
Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7666-82. doi: 10.1002/anie.201208414. Epub 2013 Jun 13.
8
Metal Complexes in Cancer Treatment: Journey So Far.癌症治疗中的金属配合物:迄今的历程
Chem Biodivers. 2023 Apr;20(4):e202300061. doi: 10.1002/cbdv.202300061. Epub 2023 Mar 13.
9
Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).抗氧化剂、体外、体内抗炎活性和消炎痛及其与锰(II)、钴(II)、镍(II)、铜(II)和锌(II)的金属配合物的增殖活性。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):742-52. doi: 10.1080/14756360802361589.
10
Anticancer metallodrugs: where is the next cisplatin?抗癌金属药物:下一个顺铂在哪里?
Future Med Chem. 2018 Mar 1;10(6):615-617. doi: 10.4155/fmc-2017-0317. Epub 2018 Feb 7.

引用本文的文献

1
Cobalt(II) Complexes of 4'-Nitro-Fenamic Acid: Characterization and Biological Evaluation.4'-硝基芬那酸的钴(II)配合物:表征与生物学评价
Molecules. 2025 Jun 17;30(12):2621. doi: 10.3390/molecules30122621.
2
Towards targeted cancer therapy: Synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex.迈向靶向癌症治疗:一种新型Cu(II)-布洛芬-2,2'-联吡啶胺金属配合物的合成、表征及生物活性
Heliyon. 2024 Dec 18;11(1):e41323. doi: 10.1016/j.heliyon.2024.e41323. eCollection 2025 Jan 15.
3
Potential Biomarkers and Treatment of Neuroinflammation in Parkinson's Disease.

本文引用的文献

1
Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH-mefenamato drug conjugates against human cancer cell lines.结构特征明确的靶向RNA的离子型非甾体抗炎药(NSAID)铜(II)和锌(II)二氨基环己烷-甲芬那酸药物缀合物对人癌细胞系的细胞毒性潜力评估。
RSC Adv. 2019 Dec 24;10(1):166-178. doi: 10.1039/c9ra07464c. eCollection 2019 Dec 20.
2
Exceptional Manganese(II) Stability and Manganese(II)/Zinc(II) Selectivity with Rigid Polydentate Ligands.刚性多齿配体赋予锰(II)卓越的稳定性及锰(II)/锌(II)选择性
Angew Chem Int Ed Engl. 2022 Mar 1;61(10):e202115580. doi: 10.1002/anie.202115580. Epub 2022 Jan 20.
3
帕金森病中神经炎症的潜在生物标志物与治疗
Actas Esp Psiquiatr. 2025 Jan;53(1):181-188. doi: 10.62641/aep.v53i1.1779.
4
Manganese(II) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure and Biological Activity.锰(II)与非甾体抗炎药的配合物:结构与生物活性
Int J Mol Sci. 2024 Dec 16;25(24):13457. doi: 10.3390/ijms252413457.
5
Predictive analysis of osteoarthritis and chronic pancreatitis comorbidity: complications and risk factors.预测分析骨关节炎和慢性胰腺炎合并症:并发症和危险因素。
Front Endocrinol (Lausanne). 2024 Nov 6;15:1492741. doi: 10.3389/fendo.2024.1492741. eCollection 2024.
6
Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer.基于非甾体类抗炎衍生物的金(I)配合物作为治疗结肠癌的多靶药物。
Inorg Chem. 2024 Oct 21;63(42):19769-19782. doi: 10.1021/acs.inorgchem.4c02988. Epub 2024 Oct 10.
7
Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study.具有潜在生物活性的二硫代氨基甲酸盐配体及其镍(II)配合物:结构、抗肿瘤及分子对接研究
Front Mol Biosci. 2023 Mar 7;10:1146820. doi: 10.3389/fmolb.2023.1146820. eCollection 2023.
Metallodrugs are unique: opportunities and challenges of discovery and development.
金属药物独具特色:发现与开发的机遇与挑战
Chem Sci. 2020 Nov 12;11(48):12888-12917. doi: 10.1039/d0sc04082g.
4
Meloxicam and Study of Their Antimicrobial Effects against Phyto- and Human Pathogens.美洛昔康及其对植物和人类病原体抗菌作用的研究。
Molecules. 2021 Mar 9;26(5):1480. doi: 10.3390/molecules26051480.
5
Mechanistic studies of in vitro anti-proliferative and anti-inflammatory activities of the Zn(ii)-NSAID complexes of 1,10-phenanthroline-5,6-dione in MDA-MB-231 cells.1,10-菲啰啉-5,6-二酮的 Zn(ii)-NSAID 配合物在 MDA-MB-231 细胞中体外抗增殖和抗炎活性的机制研究。
Dalton Trans. 2020 Aug 18;49(32):11375-11384. doi: 10.1039/d0dt01721c.
6
Biology of antimicrobial resistance and approaches to combat it.抗菌耐药性生物学及其应对方法。
Sci Transl Med. 2020 Jun 24;12(549). doi: 10.1126/scitranslmed.aaz6992.
7
Anti-Inflammatory Drugs as Anticancer Agents.抗炎药物作为抗癌药物。
Int J Mol Sci. 2020 Apr 9;21(7):2605. doi: 10.3390/ijms21072605.
8
Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance.细菌耐药性增加时代非抗生素药物的抗菌特性
Antibiotics (Basel). 2020 Mar 2;9(3):107. doi: 10.3390/antibiotics9030107.
9
Synthesis, chemical characterization and DNA interaction study of new diclofenac and ibuprofen zinc (II)-nicotinamide ternary complexes as cyclooxygenase inhibitor prototypes.新的双氯芬酸和布洛芬锌(II)-烟酰胺三元配合物的合成、化学表征及与 DNA 的相互作用研究:作为环氧化酶抑制剂的原型。
J Inorg Biochem. 2020 May;206:111046. doi: 10.1016/j.jinorgbio.2020.111046. Epub 2020 Feb 20.
10
Different Antioxidant Efficacy of Two Mn-Containing Superoxide Anion Scavengers on Hypoxia/Reoxygenation-Exposed Cardiac Muscle Cells.两种含锰的超氧阴离子清除剂对缺氧/复氧暴露的心肌细胞的抗氧化功效不同。
Sci Rep. 2019 Jul 16;9(1):10320. doi: 10.1038/s41598-019-46476-2.